MedTrace Logo

Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV

NCT01946139 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 276

Last updated 2023-11-07

Study results available
· View outcomes & findings →

Summary

This clinical trial studies anal human papillomavirus (HPV) tests in screening for cell changes in the anus in patients with human immunodeficiency virus (HIV). Screening tests may help doctors find cancer cells early and plan better treatment for anal cancer. Completing multiple screening tests may help find the best method for detecting cell changes in the anus.

Conditions

  • Anal Cancer
  • HIV Infection
  • Human Papilloma Virus Infection

Interventions

PROCEDURE

comparison of screening methods

Undergo HPV screening using HC2, APTIMA and OncoHealth HPV E6/E7 assays

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

questionnaire administration

Ancillary studies

PROCEDURE

quality-of-life assessment

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • AIDS Malignancy Consortium

    lead NETWORK

Principal Investigators

  • Elizabeth Chiao · AIDS Associated Malignancies Clinical Trials Consortium

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-04
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01946139 on ClinicalTrials.gov